Robyn Hunter - Jan 28, 2022 Form 3 Insider Report for TENAX THERAPEUTICS, INC. (TENX)

Role
Director
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact
Stock symbol
TENX
Transactions as of
Jan 28, 2022
Transactions value $
$0
Form type
3
Date filed
1/31/2022, 04:01 PM
Previous filing
Apr 29, 2022
Next filing
Jun 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TENX Common Stock 0 Jan 28, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.